X4P-001
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
WHIM Syndrome
Conditions
WHIM Syndrome
Trial Timeline
Dec 1, 2016 → Jun 16, 2022
NCT ID
NCT03005327About X4P-001
X4P-001 is a phase 2 stage product being developed by X4 Pharmaceuticals for WHIM Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT03005327. Target conditions include WHIM Syndrome.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03005327 | Phase 2 | Completed |
| NCT02680782 | Phase 1 | Terminated |
Competing Products
1 competing product in WHIM Syndrome
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Mavorixafor + Placebo | X4 Pharmaceuticals | Phase 3 | 69 |